Medical Communications

Lonza, the Basel-based supplier to the pharmaceutical, biotech and nutrition industry, has announced that it will acquire Capsugel for $5.5 …

The National Institute of Health and Care Excellence (NICE) and the US Food and Drugs Administration (FDA) have announced their …

Jeffrey Glazer, ex-CEO of Heritage Pharmaceuticals, and Jason Malek, the former president, have been charged with conspiracy to fix prices. …

Eli Lilly, Boehgringer Ingelheim, AstraZeneca UK, Grunenthal and Janssen-Cilag have been “named and shamed” by the Prescription Medicines Code of …

Bart de Strooper has been chosen as the new director of the UK Dementia Research Institute (UK DRI), and University …

As much as 35% of medicine imported into Guyana is fake and unsafe for use, according to findings by Allan …

After days of negotiations, Johnson and Johnson has stepped down from its attempts to acquire Swiss blood-pressure specialist Actelion, while …

President Barack Obama put pen to paper on the 21st Century Cures Act on 13 December, which commits to investing …

Becky Robbins, a former Healthcare Analyst at GlobalData, and Lorna Bosdet, formerly Account Executive at Sciterion have joined as Senior …

Alexion Pharmaceuticals has revealed that its CEO David Hallal (pictured) and CFO Vikas Sinha have resigned effective immediately in connection …

Alexion Pharmaceuticals has revealed that its CEO David Hallal and CFO Vikas Sinha have resigned effective immediately in connection with …

Dr Emma Harvey, ‎senior medical director at Alexion Pharmaceuticals UK, shares her views on the challenges of working in the …

Christmas is drawing ever closer, but that doesn’t mean the industry is slowing down. This week, features from the latest …

AstraZeneca has revealed that it plans to cut 700 positions across the US by 10 February 2017, including 120 positions …

Originally featured in Pharmafile Autumn 2016, a report from the United States International Trade Administration sheds light on the Chinese …